| Dementia prevention, intervention, and care: 2020 report of the Lancet Commission G Livingston, J Huntley, A Sommerlad, D Ames, C Ballard, S Banerjee, ... The Lancet 396 (10248), 413-446, 2020 | 6491 | 2020 |
| Dementia prevention, intervention, and care G Livingston, A Sommerlad, V Orgeta, SG Costafreda, J Huntley, D Ames, ... The lancet 390 (10113), 2673-2734, 2017 | 5924 | 2017 |
| Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria B Dubois, HH Feldman, C Jacova, H Hampel, JL Molinuevo, K Blennow, ... The Lancet Neurology 13 (6), 614-629, 2014 | 3538 | 2014 |
| A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease M Sano, C Ernesto, RG Thomas, MR Klauber, K Schafer, M Grundman, ... New England Journal of Medicine 336 (17), 1216-1222, 1997 | 3455 | 1997 |
| Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials LS Schneider, KS Dagerman, P Insel Jama 294 (15), 1934-1943, 2005 | 2161 | 2005 |
| Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease AC Naj, G Jun, GW Beecham, LS Wang, BN Vardarajan, J Buros, ... Nature genetics 43 (5), 436-441, 2011 | 2141 | 2011 |
| Defeating Alzheimer's disease and other dementias: a priority for European science and society B Winblad, P Amouyel, S Andrieu, C Ballard, C Brayne, H Brodaty, ... The Lancet Neurology 15 (5), 455-532, 2016 | 1772 | 2016 |
| The death toll from natural disasters: the role of income, geography, and institutions ME Kahn Review of economics and statistics 87 (2), 271-284, 2005 | 1758 | 2005 |
| Preclinical Alzheimer's disease: definition, natural history, and diagnostic criteria B Dubois, H Hampel, HH Feldman, P Scheltens, P Aisen, S Andrieu, ... Alzheimer's & Dementia 12 (3), 292-323, 2016 | 1754 | 2016 |
| The greenness of cities: Carbon dioxide emissions and urban development EL Glaeser, ME Kahn Journal of urban economics 67 (3), 404-418, 2010 | 1470 | 2010 |
| Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease LS Schneider, PN Tariot, KS Dagerman, SM Davis, JK Hsiao, MS Ismail, ... New England Journal of Medicine 355 (15), 1525-1538, 2006 | 1455 | 2006 |
| Diagnosis and treatment of Alzheimer disease and related disorders: consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and … GW Small, PV Rabins, PP Barry, NS Buckholtz, ST DeKosky, SH Ferris, ... Jama 278 (16), 1363-1371, 1997 | 1442 | 1997 |
| Sprawl and urban growth EL Glaeser, ME Kahn Handbook of regional and urban economics 4, 2481-2527, 2004 | 1440 | 2004 |
| Memantine for dementia R McShane, AA Sastre, N Minakaran Cochrane database of systematic reviews, 2006 | 1435 | 2006 |
| Analysis of shared heritability in common disorders of the brain Brainstorm Consortium, V Anttila, B Bulik-Sullivan, HK Finucane, ... Science 360 (6395), eaap8757, 2018 | 1373 | 2018 |
| A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease MJ Knapp, DS Knopman, PR Solomon, WW Pendlebury, CS Davis, ... Jama 271 (13), 985-991, 1994 | 1292 | 1994 |
| Why do the poor live in cities? The role of public transportation EL Glaeser, ME Kahn, J Rappaport Journal of urban Economics 63 (1), 1-24, 2008 | 1262 | 2008 |
| Diagnosis and treatment of depression in late life: consensus statement update BD Lebowitz, JL Pearson, LS Schneider, CF Reynolds, GS Alexopoulos, ... Jama 278 (14), 1186-1190, 1997 | 1243 | 1997 |
| Blood–brain barrier breakdown is an early biomarker of human cognitive dysfunction DA Nation, MD Sweeney, A Montagne, AP Sagare, LM D’Orazio, ... Nature medicine 25 (2), 270-276, 2019 | 1161 | 2019 |
| Internal and external influences on pro-environmental behavior: Participation in a green electricity program CF Clark, MJ Kotchen, MR Moore Journal of environmental psychology 23 (3), 237-246, 2003 | 1134 | 2003 |
